BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16025001)

  • 1. Maintaining euglycemia prevents insulin-induced Fos expression in brain autonomic regulatory circuits.
    Ao Y; Wu S; Go VL; Toy N; Yang H
    Pancreas; 2005 Aug; 31(2):142-7. PubMed ID: 16025001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract.
    Cai XJ; Evans ML; Lister CA; Leslie RA; Arch JR; Wilson S; Williams G
    Diabetes; 2001 Jan; 50(1):105-12. PubMed ID: 11147774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estradiol on glycemic and CNS neuronal activational responses to recurrent insulin-induced hypoglycemia in the ovariectomized female rat.
    Nedungadi TP; Goleman WL; Paranjape SA; Kale AY; Briski KP
    Neuroendocrinology; 2006; 84(4):235-42. PubMed ID: 17314472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal activation of brain vagal-regulatory pathways and upper gut enteric plexuses by insulin hypoglycemia.
    Yuan PQ; Yang H
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E436-48. PubMed ID: 12169436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H; Lauer G; Arnold R
    Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation.
    Paranjape SA; Briski KP
    Neuroscience; 2005; 130(4):957-70. PubMed ID: 15652993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and glucose administration stimulates Fos expression in neurones of the paraventricular nucleus that project to autonomic preganglionic structures.
    Carrasco M; Portillo F; Larsen PJ; Vallo JJ
    J Neuroendocrinol; 2001 Apr; 13(4):339-46. PubMed ID: 11264721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic hypotension causes renal and adrenal sympathoexcitaion and induces c-fos in the hypothalamus and medulla oblongata.
    Tanida M; Zhang T; Sun L; Song J; Yang W; Kuda Y; Kurata Y; Shibamoto T
    Exp Physiol; 2018 Jun; 103(6):790-806. PubMed ID: 29524326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats.
    Wang L; Martínez V; Vale W; Taché Y
    Brain Res; 2000 Feb; 855(1):47-57. PubMed ID: 10650129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent.
    Yang H; Wang L; Wu SV; Tay J; Goulet M; Boismenu R; Czimmer J; Wang Y; Wu S; Ao Y; Taché Y
    Neuroscience; 2004; 128(1):131-41. PubMed ID: 15450360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration.
    Paranjape S; Vavaiya K; Kale A; Briski K
    Neuropeptides; 2007 Apr; 41(2):111-6. PubMed ID: 17276508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I.c.v. administration of the nonsteroidal glucocorticoid receptor antagonist, CP-472555, prevents exacerbated hypoglycemia during repeated insulin administration.
    Kale AY; Paranjape SA; Briski KP
    Neuroscience; 2006 Jun; 140(2):555-65. PubMed ID: 16626867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of the hypothalamus.
    Bonaz B; Taché Y
    Brain Res; 1997 Feb; 748(1-2):12-20. PubMed ID: 9067440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracarotid glucose selectively increases Fos-like immunoreactivity in paraventricular, ventromedial and dorsomedial nuclei neurons.
    Dunn-Meynell AA; Govek E; Levin BE
    Brain Res; 1997 Feb; 748(1-2):100-6. PubMed ID: 9067450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism increases Fos immunoreactivity in cholinergic neurons of brain medullary dorsal vagal complex in rats.
    Yuan PQ; Yang H
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E892-9. PubMed ID: 15985455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat.
    Evans SB; Wilkinson CW; Bentson K; Gronbeck P; Zavosh A; Figlewicz DP
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1426-36. PubMed ID: 11641112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of luteinizing hormone secretion and expression of c-fos and corticotrophin-releasing factor genes in the paraventricular nucleus during insulin-induced hypoglycaemia in sheep.
    Adam CL; Findlay PA
    J Neuroendocrinol; 1998 Oct; 10(10):777-83. PubMed ID: 9792329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat.
    Vrang N; Larsen PJ; Kristensen P; Tang-Christensen M
    Endocrinology; 2000 Feb; 141(2):794-801. PubMed ID: 10650962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain GLUT4 Knockout Mice Have Impaired Glucose Tolerance, Decreased Insulin Sensitivity, and Impaired Hypoglycemic Counterregulation.
    Reno CM; Puente EC; Sheng Z; Daphna-Iken D; Bree AJ; Routh VH; Kahn BB; Fisher SJ
    Diabetes; 2017 Mar; 66(3):587-597. PubMed ID: 27797912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.